Headline News about Pacira Pharm Inc
![](/next-assets/images/schema-image-default.png)
What 6 Analyst Ratings Have To Say About Pacira BioSciences
April 20, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Pacira BioSciences's Future
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_132.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Pacira BioSciences
February 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Pacira BioSciences Stands With Analysts
January 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1503.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
January 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_638.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/13/image-jetblue_airways.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23453.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
December 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3740.jpeg?width=1200&height=800&fit=crop)
Pacira BioSciences's Return On Capital Employed Insights
November 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21548.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9464.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_11.png?width=1200&height=800&fit=crop)
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
September 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/07/aapharma_7.png?width=1200&height=800&fit=crop)
Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2405.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/07/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7785.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3432.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/15/price_targets.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-vertex-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_1420.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5191.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4346.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/12/yesterdays_movers.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.